CN102793813A - Healthcare product with stone resolving function - Google Patents
Healthcare product with stone resolving function Download PDFInfo
- Publication number
- CN102793813A CN102793813A CN201210325579XA CN201210325579A CN102793813A CN 102793813 A CN102793813 A CN 102793813A CN 201210325579X A CN201210325579X A CN 201210325579XA CN 201210325579 A CN201210325579 A CN 201210325579A CN 102793813 A CN102793813 A CN 102793813A
- Authority
- CN
- China
- Prior art keywords
- parts
- stone
- health product
- healthcare product
- fossil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a healthcare product with a stone resolving function. The healthcare product is prepared from the following raw materials in parts by weight: 2-4 parts of herba lysimachiae, 3-12 parts of endothelium corneum gigeriae galli, 4-16 parts of rhizoma alismatis, 5-15 parts of radix astragali, 6-24 parts of herba pyrrosiae, 1-4 parts of spora lygodii, 3-9 parts of rhizoma coptidis and 2-8 parts of flos lonicerae. In the healthcare product with a stone resolving function provided by the invention, the components are scientifically and reasonably proportioned; and the experimental result indicates that the product has good functions of resolving stone, diminishing inflammation and stopping pain, ensures little bad reaction and is safe to take.
Description
Technical field
The present invention relates to a kind of health product, be specifically related to a kind of have the fossil effect health product.
Background technology
The raising day by day of Along with people's living standard, people's dietary habit is rule not too, and crapulent situation often has generation, and erratic dietary habit causes lithiasis easily, and common have a cholelithiasis, brought very big inconvenience for people's life.Present fossil health product of the prior art are less, and the fossil effect is general.Therefore necessary on the basis of prior art, a kind of proportioning of research and development design is scientific and reasonable, the health product with fine fossil anti-inflammatory efficacy.
Summary of the invention
Goal of the invention: technical problem to be solved by this invention is the deficiency that overcomes prior art, provides a kind of proportioning scientific and reasonable, the health product with fine fossil anti-inflammatory efficacy.
Technical scheme: for solving above technical problem, the present invention takes following technical scheme:
A kind of have the fossil effect health product, it is processed by the raw material of following parts by weight:
2 ~ 4 parts of Herba Lysimachiaes, 3 ~ 12 parts of Endothelium Corneum Gigeriae Galli, 4 ~ 16 parts of Rhizoma Alismatis, 5 ~ 15 parts of the Radixs Astragali, 6 ~ 24 parts of Folium Pyrrosiae, 1 ~ 4 part of Spora Lygodii, 3 ~ 9 parts of Rhizoma Coptidis, 2 ~ 8 parts of Flos Loniceraes.
As preferred version, above-described have the fossil effect health product, it is processed by the raw material of following parts by weight:
2 ~ 3 parts of Herba Lysimachiaes, 3 ~ 9 parts of Endothelium Corneum Gigeriae Galli, 4 ~ 12 parts of Rhizoma Alismatis, 5 ~ 10 parts of the Radixs Astragali, 6 ~ 18 parts of Folium Pyrrosiae, 1 ~ 3 part of Spora Lygodii, 3 ~ 6 parts of Rhizoma Coptidis, 2 ~ 4 parts of Flos Loniceraes.
As more preferably scheme, above-described have the fossil effect health product, it is processed by the raw material of following parts by weight:
3 parts of Herba Lysimachiaes, 6 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Rhizoma Alismatis, 6 parts of the Radixs Astragali, 12 parts of Folium Pyrrosiae, 2 parts of Spora Lygodii, 4 parts of Rhizoma Coptidis, 3 parts of Flos Loniceraes.
Provided by the invention have the fossil effect health product, Herba Lysimachiae wherein, Endothelium Corneum Gigeriae Galli; Rhizoma Alismatis, the Radix Astragali, Folium Pyrrosiae and Spora Lygodii have the effect of well dissolving calculus; Wherein Rhizoma Coptidis and Flos Lonicerae have good antiphlogistic effect, have the antiinflammatory effect that relieves the pain simultaneously at calculi dissolving.
Beneficial effect: provided by the invention have the fossil effect health product compare with prior art and have following advantage:
Health product with fossil effect provided by the invention, the each component proportioning is scientific and reasonable, and experimental result shows to have the good fossil antiinflammatory effect that relieves the pain, and untoward reaction is low, takes safety.
The specific embodiment
Below in conjunction with specific embodiment; Further illustrate the present invention; Should understand these embodiment only be used to the present invention is described and be not used in the restriction scope of the present invention; After having read the present invention, those skilled in the art all fall within the application's accompanying claims institute restricted portion to the modification of the various equivalent form of values of the present invention.
Embodiment 1
A kind of have the fossil effect health product, it is processed by the raw material of following parts by weight:
4 parts of Herba Lysimachiaes, 12 parts of Endothelium Corneum Gigeriae Galli, 16 parts of Rhizoma Alismatis, 15 parts of the Radixs Astragali, 24 parts of Folium Pyrrosiae, 4 parts of Spora Lygodii, 9 parts of Rhizoma Coptidis, 8 parts of Flos Loniceraes.
Embodiment 2
A kind of have the fossil effect health product, it is processed by the raw material of following parts by weight:
2 parts of Herba Lysimachiaes, 3 parts of Endothelium Corneum Gigeriae Galli, 4 parts of Rhizoma Alismatis, 5 parts of the Radixs Astragali, 6 parts of Folium Pyrrosiae, 1 part of Spora Lygodii, 3 parts of Rhizoma Coptidis, 2 parts of Flos Loniceraes.
Embodiment 3
A kind of have the fossil effect health product, it is processed by the raw material of following parts by weight:
3 parts of Herba Lysimachiaes, 9 parts of Endothelium Corneum Gigeriae Galli, 12 parts of Rhizoma Alismatis, 10 parts of the Radixs Astragali, 18 parts of Folium Pyrrosiae, 3 parts of Spora Lygodii, 6 parts of Rhizoma Coptidis, 4 parts of Flos Loniceraes.
Embodiment 4
A kind of have the fossil effect health product, it is processed by the raw material of following parts by weight:
3 parts of Herba Lysimachiaes, 6 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Rhizoma Alismatis, 6 parts of the Radixs Astragali, 12 parts of Folium Pyrrosiae, 2 parts of Spora Lygodii, 4 parts of Rhizoma Coptidis, 3 parts of Flos Loniceraes.
The above only is a preferred implementation of the present invention; Should be pointed out that for those skilled in the art, under the prerequisite that does not break away from the principle of the invention; Can also make some improvement and retouching, these improvement and retouching also should be regarded as protection scope of the present invention.
Claims (3)
- One kind have the fossil effect health product, it is characterized in that it is processed by the raw material of following parts by weight:2 ~ 4 parts of Herba Lysimachiaes, 3 ~ 12 parts of Endothelium Corneum Gigeriae Galli, 4 ~ 16 parts of Rhizoma Alismatis, 5 ~ 15 parts of the Radixs Astragali, 6 ~ 24 parts of Folium Pyrrosiae, 1 ~ 4 part of Spora Lygodii, 3 ~ 9 parts of Rhizoma Coptidis, 2 ~ 8 parts of Flos Loniceraes.
- 2. according to claim 1 have the fossil effect health product, it is characterized in that it is processed by the raw material of following parts by weight:2 ~ 3 parts of Herba Lysimachiaes, 3 ~ 9 parts of Endothelium Corneum Gigeriae Galli, 4 ~ 12 parts of Rhizoma Alismatis, 5 ~ 10 parts of the Radixs Astragali, 6 ~ 18 parts of Folium Pyrrosiae, 1 ~ 3 part of Spora Lygodii, 3 ~ 6 parts of Rhizoma Coptidis, 2 ~ 4 parts of Flos Loniceraes.
- 3. according to claim 2 have the fossil effect health product, it is characterized in that it is processed by the raw material of following parts by weight:3 parts of Herba Lysimachiaes, 6 parts of Endothelium Corneum Gigeriae Galli, 8 parts of Rhizoma Alismatis, 6 parts of the Radixs Astragali, 12 parts of Folium Pyrrosiae, 2 parts of Spora Lygodii, 4 parts of Rhizoma Coptidis, 3 parts of Flos Loniceraes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210325579XA CN102793813A (en) | 2012-09-06 | 2012-09-06 | Healthcare product with stone resolving function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210325579XA CN102793813A (en) | 2012-09-06 | 2012-09-06 | Healthcare product with stone resolving function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102793813A true CN102793813A (en) | 2012-11-28 |
Family
ID=47193282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210325579XA Pending CN102793813A (en) | 2012-09-06 | 2012-09-06 | Healthcare product with stone resolving function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102793813A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922236A (en) * | 2015-06-30 | 2015-09-23 | 贵州黄平靓鸥桑综合开发有限公司 | Drink for treating gall-stone |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101647931A (en) * | 2009-09-18 | 2010-02-17 | 秦中文 | Traditional Chinese medicine for promoting urination and dissolving and discharging calculus |
| CN101972447A (en) * | 2010-09-29 | 2011-02-16 | 韩世昌 | Traditional Chinese medicine oral liquid for treating cholecystitis and gallstones and preparation method thereof |
-
2012
- 2012-09-06 CN CN201210325579XA patent/CN102793813A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101647931A (en) * | 2009-09-18 | 2010-02-17 | 秦中文 | Traditional Chinese medicine for promoting urination and dissolving and discharging calculus |
| CN101972447A (en) * | 2010-09-29 | 2011-02-16 | 韩世昌 | Traditional Chinese medicine oral liquid for treating cholecystitis and gallstones and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈忠坚: "化石排石汤治疗泌尿系结石", 《医学信息(上旬刊)》, vol. 23, no. 6, 30 June 2010 (2010-06-30), pages 1931 - 1932 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922236A (en) * | 2015-06-30 | 2015-09-23 | 贵州黄平靓鸥桑综合开发有限公司 | Drink for treating gall-stone |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY172035A (en) | A medicinal composition for the treatment of bronchitis and preparation thereof | |
| CN102860967A (en) | Baby skin care product formula possessing functions of eliminating miliaria and relieving itching | |
| CN101721616A (en) | Medicine for stopping bleeding | |
| CN102793813A (en) | Healthcare product with stone resolving function | |
| CN105920338A (en) | Tea bag for removing chloasma | |
| CN101284117A (en) | Stone-dissolving good prescription | |
| CN103816285A (en) | External ointment for treating manus and tinea pedis and preparation method of external ointment | |
| CN102370717A (en) | Medicine for treating conjunctivitis | |
| CN102370785A (en) | Medicine for treating oral ulcer | |
| CN102380021A (en) | Chinese medicinal formula for treating insomnia | |
| CN1714835A (en) | Chinese herbal medicine for treating acne and fester | |
| CN1219522C (en) | Hard capsule of superfine notoginseng powder | |
| CN102793807A (en) | Plant extract with gastritis conditioning function | |
| CN102940789A (en) | Chinese medicament for treating liver-yang headache | |
| CN103585217A (en) | Setose thistle/herba cephalanoploris pill | |
| CN104688851A (en) | Chinese herbal medicine prescription for treating cerebral hemorrhage | |
| CN102370880A (en) | Drug for treating lumbago caused by arthromyodynia | |
| CN103417434A (en) | Antipruritic body lotion | |
| CN103830475A (en) | Traditional Chinese medicine indico naturalis powder for treating abscess | |
| CN103494926A (en) | External medicine for treating rosacea and acne | |
| CN103961446A (en) | Quick-acting aphtha powder | |
| CN102370780A (en) | Traditional Chinese medicine powder for treating hernia | |
| CN102872317A (en) | Chinese medicinal prescription for removing acne and preparation method thereof | |
| CN101513490A (en) | Method for preparing anti-acne decoction | |
| CN102885963A (en) | Powder for treating acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121128 |